[1]
Ness-Jensen, E.; Lagergren, J. Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease. Best Pract. Res. Clin. Gastroenterol., 2017, 31(5), 501-508.
[2]
Chen, X.; Li, P.; Wang, F.; Ji, G.; Miao, L.; You, S. Psychological results of 438 patients with persisting gastroesophageal reflux disease symptoms by symptom checklist 90-revised questionnaire. Euroasian J. Hepatogastroenterol, 2017, 7(2), 117-121.
[3]
Li, N.; Cao, M.; Yi, S.; Cheng, J.; Wang, L.; Tao, Y.; Wu, D.; Peng, J.; Zhang, M.; Qi, P.; Zhao, J. Effects of the RNA-binding protein, KSRP, on innate immune response against Helicobacter pylori infection in mice. Biochem. Biophys. Res. Commun., 2017, 17, 32401-32404.
[4]
Ma, J.; Hiratsuka, T.; Etoh, T.; Akada, J.; Fujishima, H.; Shiraishi, N.; Yamaoka, Y.; Inomata, M. Anti-proliferation effect of blue light-emitting diodes against antibiotic-resistant Helicobacter pylori. J. Gastroenterol. Hepatol., 2017, 33(8), 1492-1499.
[5]
Preda, C.M.; Proca, D.; Sandra, I.; Fulger, L.E.; Horeanga, B.C.; Manuc, M.; Manuc, T.; Dute, C.A.; Barbu, M.; Tugui, L.; Andrei, A.C.; Slavulete, B.I.; Diculescu, M. A comparative study of efficacy and safety of two eradication regimens for helicobacter pylori infection. Maedica (Buchar.), 2017, 12(3), 157-163.
[6]
Kao, C.Y.; Sheu, B.S.; Wu, J.J. Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis. Biomed. J., 2016, 39, 14-23.
[7]
Ruiter, R.; Wunderink, H.F.; Veenendaal, R.A.; Visser, L.G.; Boer, M.G.J. Helicobacter pylori resistance in the Netherlands: A growing problem? Neth. J. Med., 2017, 75(9), 394-398.
[8]
Phull, A.R.; Hassan, M.; Abbas, Q.; Raza, H.; Haq, I.U.; Seo, S.Y.; Kim, S.J. In-vitro, in silico elucidation of antiurease activity, kinetic mechanism and COX-2 inhibitory efficacy of Coagulansin-A of Withania coagulans. Chem. Biodivers., 2017, 15(1), e1700427.
[9]
Schwartz, J.T.; Allen, L.A. Role of urease in megasome formation and Helicobacter pylori survival in macrophages. J. Leukoc. Biol., 2006, 79, 1214-1225.
[10]
Eaton, K.A.; Brooks, C.L.; Morgan, D.R.; Krakowka, S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun., 1991, 59, 2470-2475.
[11]
Schoep, T.D.; Fulurija, A.; Good, F.; Lu, W.; Himbeck, R.P.; Schwan, C. Surface properties of Helicobacter pylori urease complex are essential for persistence. PLoS One, 2010, 5, 15-42.
[12]
Campanale, M.; Nucera, E.; Ojetti, V.; Cesario, V.; Di Rienzo, T.A.; D’Angelo, G. Nickel free-diet enhances the Helicobacter pylori eradication rate: A pilot study. Dig. Dis. Sci., 2014, 59, 1851-1855.
[13]
Stéphane, L.; Benoit, A.L. Zbell, Robert, J. Maier. Nickel enzyme maturation in Helicobacter hepaticus: Roles of accessory proteins in hydrogenase and urease activities. Microbiology, 2007, 153(Pt 11), 3748-3756.
[14]
Olson, J.W.; Mehta, N.S.; Maier, R.J. Requirement of nickel metabolism proteins HypA and HypB for full activity of both hydrogenase and urease in Helicobacter pylori. Mol. Microbiol., 2001, 39(1), 176-182.
[15]
Taha, M.; Ismail, N.H.; Imran, S.; Wadood, A.; Rahim, F.; Khan, K.M.; Riaz, M. Hybrid benzothiazole analogs as antiurease agent: Synthesis and molecular docking studies. Bioorg. Chem., 2016, 66, 80-87.
[16]
Upadhyay, L.S.B. Urease inhibitors: A review. Indian J. Biotechnol., 2012, 11, 381-388.
[17]
Abid, O.U.R.; Babar, T.M.; Ali, F.I. Identification of novel urease inhibitors by high-throughput virtual and in vitro screening. ACS Med. Chem. Lett., 2010, 1(4), 145-149.
[18]
Serwar, M.; Akhtar, T.; Hameed, S.; Khan, K. Synthesis, urease inhibition and antimicrobial activities of some chiral 5-aryl-4-(1-phenylpropyl)-2H-1,2,4-triazole-3(4H)-thiones. ARKIVOC, 2009, 7, 210-221.
[19]
Küçükgüzel, Ş.G.; Mazi, A.; Sahin, F.; Öztürk, S.; Stables, J. Synthesis and biological activities of diflunisal hydrazide-hydrazones. Eur. J. Med. Chem., 2003, 38, 1005-1013.
[20]
Kalaycı, S.; Demirci, S.; Sahin, F. Antimicrobial properties of various psychotropic drugs against broad range microorganisms. Curr. Psychopharmacol., 2014, 3(3), 195-202.
[21]
Huang, J.; Zhou, J.; Song, S.; Song, H.; Chen, Z.; Yi, W. A new and efficient ZnCl2-catalyzed synthesis and biological evaluation of novel 2-amino-3,5-dicyano-4-aryl-6-aryl-aminopyridines as potent antibacterial agents against Helicobacter Pylori (HP). Tetrahedron, 2015, 8628-8636.
[22]
Küçükgüzel, Ş.G.; Kocatepe, A.; Clercq, E.D.; Şahin, F.; Güllüce, M. Synthesis and biological activity of 4-thiazolidinones, thiosemicarbazides derived from diflunisal hydrazide. Eur. J. Med. Chem., 2006, 41, 353-359.
[23]
Küçükgüzel, Ş.G.; Küçükgüzel, İ.; Tatar, E.; Rollas, S.; Şahin, F.; Güllüce, M. Clercq, Erik De; Kabasakal, L. Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti-infective and anti-inflammatory agents. Eur. J. Med. Chem., 2007, 42, 893-901.
[24]
Khan, I.; Ali, S.; Hameed, S.; Rama, N.H.; Hussain, M.T.; Wadood, A.; Uddin, R.; Ul-Haq, Z.; Khan, A.; Ali, S.; Choudhary, M.I. Synthesis, antioxidant activities and urease inhibition of some new 1,2,4-triazole and 1,3,4-thiadiazole derivatives. Eur. J. Med. Chem., 2010, 45, 5200-5207.
38
3